Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermal Necrolysis”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Not applicableUnknownNCT02574988
What this trial is testing

Severe Cutaneous Adverse Reactions in Thailand

Who this might be right for
Steven-Johnson SyndromeToxic Epidermal NecrolysisDrug Reaction With Eosinophilia and Systemic Symptoms+2 more
Chulalongkorn University 200
Large-scale testing (Phase 3)Study completedNCT02987257
What this trial is testing

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolyses
Vanderbilt University Medical Center 2
Not applicableUnknownNCT05145959
What this trial is testing

Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal NecrolysesOcular Surface Disease+3 more
Massachusetts Eye and Ear Infirmary 30
Large-scale testing (Phase 3)Study completedNCT01696500
What this trial is testing

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Nihon Pharmaceutical Co., Ltd 10
Not applicableWithdrawnNCT02795143
What this trial is testing

Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study

Who this might be right for
Toxic Epidermal Necrolysis
Massachusetts General Hospital
Not applicableStudy completedNCT06474078
What this trial is testing

Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Chang Gung Memorial Hospital 20
Large-scale testing (Phase 3)UnknownNCT04651439
What this trial is testing

Severe Bullous Drug Eruption and Filgrastim

Who this might be right for
Rare DiseasesToxic Epidermal Necrolyses
Hospices Civils de Lyon 42
Very early researchLooking for participantsNCT06119490
What this trial is testing

Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
Peng Zhang 30
Not applicableUnknownNCT03839069
What this trial is testing

Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis

Who this might be right for
Cicatrizing ConjunctivitisStevens-Johnson Syndrome Toxic Epidermal Necrolysis SpectrumSjogren Syndrome+3 more
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT02126020
What this trial is testing

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis (Lyell) SyndromeMucous Membrane Pemphigoid
James Chodosh, MD, MPH
Post-approval studies (Phase 4)Not Yet RecruitingNCT07369622
What this trial is testing

HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness

Who this might be right for
Gout Initiating Urate-loweringUrate-lowering TherapyGout ArthritisGout and Hyperuricemia
Haiphong University of Medicine and Pharmacy 228
Not applicableWithdrawnNCT03585946
What this trial is testing

Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal NecrolysisDrug Reaction
Massachusetts General Hospital
Testing effectiveness (Phase 2)Ended earlyNCT02037347
What this trial is testing

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal NecrolysisStevens-Johnson Syndrome
Brett King 1
Testing effectiveness (Phase 2)Looking for participantsNCT04711200
What this trial is testing

LYell SYndrome MEsenchymal Stromal Cells Treatment

Who this might be right for
Epidermal NecrolysisLyell SyndromeToxic Epidermal Necrolysis+3 more
Assistance Publique - Hôpitaux de Paris 15
Not applicableStudy completedNCT06522048
What this trial is testing

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

Who this might be right for
Immune Checkpoint Inhibitor-Induced DermatitisStevens-Johnson Syndrome, Drug-InducedToxic Epidermal Necrolysis Due to Drug
Chao Ji 300
Not applicableUnknownNCT04252651
What this trial is testing

Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients

Who this might be right for
Inflammatory ResponseMulti Organ FailureNosocomial Infection+1 more
Joseph M. Still Research Foundation, Inc. 65
Post-approval studies (Phase 4)Study completedNCT02739295
What this trial is testing

G-CSF in the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Stevens - Johnson Syndrome
University of Liege 10
Testing effectiveness (Phase 2)WithdrawnNCT02319616
What this trial is testing

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
University of California, Davis
Load More Results